2
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1563 |
Nifuroxazide
Diarlidan,硝呋齐特,Nifuroxazid,Dicoferin,硝呋酚酰肼 |
Antibacterial; Antibiotic; STAT | JAK/STAT signaling; Microbiology/Virology; Stem Cells |
Nifuroxazide (Diarlidan) 是STAT3抑制剂,具有抗转移和抗癌活性。 | |||
T71291 |
EICAR
|
Others | Others |
EICAR is a drug which acts as an inhibitor of the enzyme IMP dehydrogenase. It is a nucleoside derivative which has both anti-cancer and antiviral effects, and was originally developed for the treatment of leukemia, but was unsuccessful in human clinical trials. It has broad spectrum antiviral effects with activity against vaccinia virus, Semliki forest virus, Junin virus, reovirus, influenza, measles virus and respiratory syncytial virus among others, although it is not active against SARS. T... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T71293 |
Nifuroxazide-d4
|
||
Nifuroxazide-d4 is intended for use as an internal standard for the quantification of nifuroxazide by GC- or LC-MS. Nifuroxazide is a nitrofuran antibiotic. It is active against strains of the enteropathogenic bacteria C. jejuni, Salmonella, Y. enterocolitica, Shigella, and E. coli. It inhibits quorum sensing and virulence factor production in P. aeruginosa. Nifuroxazide inhibits STAT3 activity in a reporter assay and decreases viability of U266 and INA-6 myeloma cells, which have constitutive S... |